世界の成長ホルモン欠乏療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Growth Hormone Deficiency Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5761
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、119ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、成長ホルモン欠乏療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非経口、経皮、経口、その他）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・成長ホルモン欠乏療法の市場動向
・企業の競争状況、市場シェア
・成長ホルモン欠乏療法の種類別市場規模と予測2016-2027（非経口、経皮、経口、その他）
・成長ホルモン欠乏療法の用途別市場規模と予測2016-2027（病院、ドラッグストア、その他）
・成長ホルモン欠乏療法の北米市場規模2016-2027（アメリカ、カナダ）
・成長ホルモン欠乏療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・成長ホルモン欠乏療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・成長ホルモン欠乏療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・成長ホルモン欠乏療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Eli Lilly、Pfizer、AbbVie、Novo Nordisk、Merck KGaA、Mylan、Bayer、Teva、Novartis、Abbott、Roche、Endo International、Ipsen、ANI Pharmaceuticals、TherapeuticsMD）
・結論

Growth hormone deficiency (GHD) is a medical condition due to not enough growth hormone (GH). … Some cases are associated with a lack of other pituitary hormones, in which case it is known as combined pituitary hormone deficiency. Diagnosis involves blood tests to measure growth hormone levels.

Market Analysis and Insights: Global Growth Hormone Deficiency Therapy Market
The global Growth Hormone Deficiency Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Growth Hormone Deficiency Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Growth Hormone Deficiency Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Growth Hormone Deficiency Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Growth Hormone Deficiency Therapy market.

Global Growth Hormone Deficiency Therapy Scope and Market Size
Growth Hormone Deficiency Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Growth Hormone Deficiency Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Parenteral
Transdermal
Oral
Others

Segment by Application
Hospitals
Drugstores
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Growth Hormone Deficiency Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Parenteral
1.2.3 Transdermal
1.2.4 Oral
1.2.5 Others
1.3 Market by Application
1.3.1 Global Growth Hormone Deficiency Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Growth Hormone Deficiency Therapy Market Perspective (2016-2027)
2.2 Growth Hormone Deficiency Therapy Growth Trends by Regions
2.2.1 Growth Hormone Deficiency Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Growth Hormone Deficiency Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Growth Hormone Deficiency Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Growth Hormone Deficiency Therapy Industry Dynamic
2.3.1 Growth Hormone Deficiency Therapy Market Trends
2.3.2 Growth Hormone Deficiency Therapy Market Drivers
2.3.3 Growth Hormone Deficiency Therapy Market Challenges
2.3.4 Growth Hormone Deficiency Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Growth Hormone Deficiency Therapy Players by Revenue
3.1.1 Global Top Growth Hormone Deficiency Therapy Players by Revenue (2016-2021)
3.1.2 Global Growth Hormone Deficiency Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Growth Hormone Deficiency Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Growth Hormone Deficiency Therapy Revenue
3.4 Global Growth Hormone Deficiency Therapy Market Concentration Ratio
3.4.1 Global Growth Hormone Deficiency Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Growth Hormone Deficiency Therapy Revenue in 2020
3.5 Growth Hormone Deficiency Therapy Key Players Head office and Area Served
3.6 Key Players Growth Hormone Deficiency Therapy Product Solution and Service
3.7 Date of Enter into Growth Hormone Deficiency Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Growth Hormone Deficiency Therapy Breakdown Data by Type
4.1 Global Growth Hormone Deficiency Therapy Historic Market Size by Type (2016-2021)
4.2 Global Growth Hormone Deficiency Therapy Forecasted Market Size by Type (2022-2027)

5 Growth Hormone Deficiency Therapy Breakdown Data by Application
5.1 Global Growth Hormone Deficiency Therapy Historic Market Size by Application (2016-2021)
5.2 Global Growth Hormone Deficiency Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Growth Hormone Deficiency Therapy Market Size (2016-2027)
6.2 North America Growth Hormone Deficiency Therapy Market Size by Type
6.2.1 North America Growth Hormone Deficiency Therapy Market Size by Type (2016-2021)
6.2.2 North America Growth Hormone Deficiency Therapy Market Size by Type (2022-2027)
6.2.3 North America Growth Hormone Deficiency Therapy Market Size by Type (2016-2027)
6.3 North America Growth Hormone Deficiency Therapy Market Size by Application
6.3.1 North America Growth Hormone Deficiency Therapy Market Size by Application (2016-2021)
6.3.2 North America Growth Hormone Deficiency Therapy Market Size by Application (2022-2027)
6.3.3 North America Growth Hormone Deficiency Therapy Market Size by Application (2016-2027)
6.4 North America Growth Hormone Deficiency Therapy Market Size by Country
6.4.1 North America Growth Hormone Deficiency Therapy Market Size by Country (2016-2021)
6.4.2 North America Growth Hormone Deficiency Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Growth Hormone Deficiency Therapy Market Size (2016-2027)
7.2 Europe Growth Hormone Deficiency Therapy Market Size by Type
7.2.1 Europe Growth Hormone Deficiency Therapy Market Size by Type (2016-2021)
7.2.2 Europe Growth Hormone Deficiency Therapy Market Size by Type (2022-2027)
7.2.3 Europe Growth Hormone Deficiency Therapy Market Size by Type (2016-2027)
7.3 Europe Growth Hormone Deficiency Therapy Market Size by Application
7.3.1 Europe Growth Hormone Deficiency Therapy Market Size by Application (2016-2021)
7.3.2 Europe Growth Hormone Deficiency Therapy Market Size by Application (2022-2027)
7.3.3 Europe Growth Hormone Deficiency Therapy Market Size by Application (2016-2027)
7.4 Europe Growth Hormone Deficiency Therapy Market Size by Country
7.4.1 Europe Growth Hormone Deficiency Therapy Market Size by Country (2016-2021)
7.4.2 Europe Growth Hormone Deficiency Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Growth Hormone Deficiency Therapy Market Size (2016-2027)
8.2 Asia-Pacific Growth Hormone Deficiency Therapy Market Size by Type
8.2.1 Asia-Pacific Growth Hormone Deficiency Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Growth Hormone Deficiency Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Growth Hormone Deficiency Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Growth Hormone Deficiency Therapy Market Size by Application
8.3.1 Asia-Pacific Growth Hormone Deficiency Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Growth Hormone Deficiency Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Growth Hormone Deficiency Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Growth Hormone Deficiency Therapy Market Size by Region
8.4.1 Asia-Pacific Growth Hormone Deficiency Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Growth Hormone Deficiency Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Growth Hormone Deficiency Therapy Market Size (2016-2027)
9.2 Latin America Growth Hormone Deficiency Therapy Market Size by Type
9.2.1 Latin America Growth Hormone Deficiency Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Growth Hormone Deficiency Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Growth Hormone Deficiency Therapy Market Size by Type (2016-2027)
9.3 Latin America Growth Hormone Deficiency Therapy Market Size by Application
9.3.1 Latin America Growth Hormone Deficiency Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Growth Hormone Deficiency Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Growth Hormone Deficiency Therapy Market Size by Application (2016-2027)
9.4 Latin America Growth Hormone Deficiency Therapy Market Size by Country
9.4.1 Latin America Growth Hormone Deficiency Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Growth Hormone Deficiency Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Growth Hormone Deficiency Therapy Market Size (2016-2027)
10.2 Middle East & Africa Growth Hormone Deficiency Therapy Market Size by Type
10.2.1 Middle East & Africa Growth Hormone Deficiency Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Growth Hormone Deficiency Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Growth Hormone Deficiency Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Growth Hormone Deficiency Therapy Market Size by Application
10.3.1 Middle East & Africa Growth Hormone Deficiency Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Growth Hormone Deficiency Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Growth Hormone Deficiency Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Growth Hormone Deficiency Therapy Market Size by Country
10.4.1 Middle East & Africa Growth Hormone Deficiency Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Growth Hormone Deficiency Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Growth Hormone Deficiency Therapy Introduction
11.1.4 Eli Lilly Revenue in Growth Hormone Deficiency Therapy Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Growth Hormone Deficiency Therapy Introduction
11.2.4 Pfizer Revenue in Growth Hormone Deficiency Therapy Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Growth Hormone Deficiency Therapy Introduction
11.3.4 AbbVie Revenue in Growth Hormone Deficiency Therapy Business (2016-2021)
11.3.5 AbbVie Recent Development
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Details
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Growth Hormone Deficiency Therapy Introduction
11.4.4 Novo Nordisk Revenue in Growth Hormone Deficiency Therapy Business (2016-2021)
11.4.5 Novo Nordisk Recent Development
11.5 Merck KGaA
11.5.1 Merck KGaA Company Details
11.5.2 Merck KGaA Business Overview
11.5.3 Merck KGaA Growth Hormone Deficiency Therapy Introduction
11.5.4 Merck KGaA Revenue in Growth Hormone Deficiency Therapy Business (2016-2021)
11.5.5 Merck KGaA Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Mylan Business Overview
11.6.3 Mylan Growth Hormone Deficiency Therapy Introduction
11.6.4 Mylan Revenue in Growth Hormone Deficiency Therapy Business (2016-2021)
11.6.5 Mylan Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Growth Hormone Deficiency Therapy Introduction
11.7.4 Bayer Revenue in Growth Hormone Deficiency Therapy Business (2016-2021)
11.7.5 Bayer Recent Development
11.8 Teva
11.8.1 Teva Company Details
11.8.2 Teva Business Overview
11.8.3 Teva Growth Hormone Deficiency Therapy Introduction
11.8.4 Teva Revenue in Growth Hormone Deficiency Therapy Business (2016-2021)
11.8.5 Teva Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Growth Hormone Deficiency Therapy Introduction
11.9.4 Novartis Revenue in Growth Hormone Deficiency Therapy Business (2016-2021)
11.9.5 Novartis Recent Development
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Growth Hormone Deficiency Therapy Introduction
11.10.4 Abbott Revenue in Growth Hormone Deficiency Therapy Business (2016-2021)
11.10.5 Abbott Recent Development
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Growth Hormone Deficiency Therapy Introduction
11.11.4 Roche Revenue in Growth Hormone Deficiency Therapy Business (2016-2021)
11.11.5 Roche Recent Development
11.12 Endo International
11.12.1 Endo International Company Details
11.12.2 Endo International Business Overview
11.12.3 Endo International Growth Hormone Deficiency Therapy Introduction
11.12.4 Endo International Revenue in Growth Hormone Deficiency Therapy Business (2016-2021)
11.12.5 Endo International Recent Development
11.13 Ipsen
11.13.1 Ipsen Company Details
11.13.2 Ipsen Business Overview
11.13.3 Ipsen Growth Hormone Deficiency Therapy Introduction
11.13.4 Ipsen Revenue in Growth Hormone Deficiency Therapy Business (2016-2021)
11.13.5 Ipsen Recent Development
11.14 ANI Pharmaceuticals
11.14.1 ANI Pharmaceuticals Company Details
11.14.2 ANI Pharmaceuticals Business Overview
11.14.3 ANI Pharmaceuticals Growth Hormone Deficiency Therapy Introduction
11.14.4 ANI Pharmaceuticals Revenue in Growth Hormone Deficiency Therapy Business (2016-2021)
11.14.5 ANI Pharmaceuticals Recent Development
11.15 TherapeuticsMD
11.15.1 TherapeuticsMD Company Details
11.15.2 TherapeuticsMD Business Overview
11.15.3 TherapeuticsMD Growth Hormone Deficiency Therapy Introduction
11.15.4 TherapeuticsMD Revenue in Growth Hormone Deficiency Therapy Business (2016-2021)
11.15.5 TherapeuticsMD Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Growth Hormone Deficiency Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Parenteral
Table 3. Key Players of Transdermal
Table 4. Key Players of Oral
Table 5. Key Players of Others
Table 6. Global Growth Hormone Deficiency Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Growth Hormone Deficiency Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Growth Hormone Deficiency Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Growth Hormone Deficiency Therapy Market Share by Regions (2016-2021)
Table 10. Global Growth Hormone Deficiency Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Growth Hormone Deficiency Therapy Market Share by Regions (2022-2027)
Table 12. Growth Hormone Deficiency Therapy Market Trends
Table 13. Growth Hormone Deficiency Therapy Market Drivers
Table 14. Growth Hormone Deficiency Therapy Market Challenges
Table 15. Growth Hormone Deficiency Therapy Market Restraints
Table 16. Global Growth Hormone Deficiency Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Growth Hormone Deficiency Therapy Market Share by Players (2016-2021)
Table 18. Global Top Growth Hormone Deficiency Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Growth Hormone Deficiency Therapy as of 2020)
Table 19. Ranking of Global Top Growth Hormone Deficiency Therapy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Growth Hormone Deficiency Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Growth Hormone Deficiency Therapy Product Solution and Service
Table 23. Date of Enter into Growth Hormone Deficiency Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Growth Hormone Deficiency Therapy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Growth Hormone Deficiency Therapy Revenue Market Share by Type (2016-2021)
Table 27. Global Growth Hormone Deficiency Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Growth Hormone Deficiency Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Growth Hormone Deficiency Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Growth Hormone Deficiency Therapy Revenue Market Share by Application (2016-2021)
Table 31. Global Growth Hormone Deficiency Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Growth Hormone Deficiency Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Growth Hormone Deficiency Therapy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Growth Hormone Deficiency Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Growth Hormone Deficiency Therapy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Growth Hormone Deficiency Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Growth Hormone Deficiency Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Growth Hormone Deficiency Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Growth Hormone Deficiency Therapy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Growth Hormone Deficiency Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Growth Hormone Deficiency Therapy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Growth Hormone Deficiency Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Growth Hormone Deficiency Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Growth Hormone Deficiency Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Growth Hormone Deficiency Therapy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Growth Hormone Deficiency Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Growth Hormone Deficiency Therapy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Growth Hormone Deficiency Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Growth Hormone Deficiency Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Growth Hormone Deficiency Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Growth Hormone Deficiency Therapy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Growth Hormone Deficiency Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Growth Hormone Deficiency Therapy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Growth Hormone Deficiency Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Growth Hormone Deficiency Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Growth Hormone Deficiency Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Growth Hormone Deficiency Therapy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Growth Hormone Deficiency Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Growth Hormone Deficiency Therapy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Growth Hormone Deficiency Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Growth Hormone Deficiency Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Growth Hormone Deficiency Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 63. Eli Lilly Company Details
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Growth Hormone Deficiency Therapy Product
Table 66. Eli Lilly Revenue in Growth Hormone Deficiency Therapy Business (2016-2021) & (US$ Million)
Table 67. Eli Lilly Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Growth Hormone Deficiency Therapy Product
Table 71. Pfizer Revenue in Growth Hormone Deficiency Therapy Business (2016-2021) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. AbbVie Company Details
Table 74. AbbVie Business Overview
Table 75. AbbVie Growth Hormone Deficiency Therapy Product
Table 76. AbbVie Revenue in Growth Hormone Deficiency Therapy Business (2016-2021) & (US$ Million)
Table 77. AbbVie Recent Development
Table 78. Novo Nordisk Company Details
Table 79. Novo Nordisk Business Overview
Table 80. Novo Nordisk Growth Hormone Deficiency Therapy Product
Table 81. Novo Nordisk Revenue in Growth Hormone Deficiency Therapy Business (2016-2021) & (US$ Million)
Table 82. Novo Nordisk Recent Development
Table 83. Merck KGaA Company Details
Table 84. Merck KGaA Business Overview
Table 85. Merck KGaA Growth Hormone Deficiency Therapy Product
Table 86. Merck KGaA Revenue in Growth Hormone Deficiency Therapy Business (2016-2021) & (US$ Million)
Table 87. Merck KGaA Recent Development
Table 88. Mylan Company Details
Table 89. Mylan Business Overview
Table 90. Mylan Growth Hormone Deficiency Therapy Product
Table 91. Mylan Revenue in Growth Hormone Deficiency Therapy Business (2016-2021) & (US$ Million)
Table 92. Mylan Recent Development
Table 93. Bayer Company Details
Table 94. Bayer Business Overview
Table 95. Bayer Growth Hormone Deficiency Therapy Product
Table 96. Bayer Revenue in Growth Hormone Deficiency Therapy Business (2016-2021) & (US$ Million)
Table 97. Bayer Recent Development
Table 98. Teva Company Details
Table 99. Teva Business Overview
Table 100. Teva Revenue in Growth Hormone Deficiency Therapy Business (2016-2021) & (US$ Million)
Table 101. Teva Recent Development
Table 102. Novartis Company Details
Table 103. Novartis Business Overview
Table 104. Novartis Growth Hormone Deficiency Therapy Product
Table 105. Novartis Revenue in Growth Hormone Deficiency Therapy Business (2016-2021) & (US$ Million)
Table 106. Novartis Recent Development
Table 107. Abbott Company Details
Table 108. Abbott Business Overview
Table 109. Abbott Growth Hormone Deficiency Therapy Product
Table 110. Abbott Revenue in Growth Hormone Deficiency Therapy Business (2016-2021) & (US$ Million)
Table 111. Abbott Recent Development
Table 112. Roche Company Details
Table 113. Roche Business Overview
Table 114. Roche Growth Hormone Deficiency Therapy Product
Table 115. Roche Revenue in Growth Hormone Deficiency Therapy Business (2016-2021) & (US$ Million)
Table 116. Roche Recent Development
Table 117. Endo International Company Details
Table 118. Endo International Business Overview
Table 119. Endo International Growth Hormone Deficiency Therapy Product
Table 120. Endo International Revenue in Growth Hormone Deficiency Therapy Business (2016-2021) & (US$ Million)
Table 121. Endo International Recent Development
Table 122. Ipsen Company Details
Table 123. Ipsen Business Overview
Table 124. Ipsen Growth Hormone Deficiency Therapy Product
Table 125. Ipsen Revenue in Growth Hormone Deficiency Therapy Business (2016-2021) & (US$ Million)
Table 126. Ipsen Recent Development
Table 127. ANI Pharmaceuticals Company Details
Table 128. ANI Pharmaceuticals Business Overview
Table 129. ANI Pharmaceuticals Growth Hormone Deficiency Therapy Product
Table 130. ANI Pharmaceuticals Revenue in Growth Hormone Deficiency Therapy Business (2016-2021) & (US$ Million)
Table 131. ANI Pharmaceuticals Recent Development
Table 132. TherapeuticsMD Company Details
Table 133. TherapeuticsMD Business Overview
Table 134. TherapeuticsMD Growth Hormone Deficiency Therapy Product
Table 135. TherapeuticsMD Revenue in Growth Hormone Deficiency Therapy Business (2016-2021) & (US$ Million)
Table 136. TherapeuticsMD Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Growth Hormone Deficiency Therapy Market Share by Type: 2020 VS 2027
Figure 2. Parenteral Features
Figure 3. Transdermal Features
Figure 4. Oral Features
Figure 5. Others Features
Figure 6. Global Growth Hormone Deficiency Therapy Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Drugstores Case Studies
Figure 9. Others Case Studies
Figure 10. Growth Hormone Deficiency Therapy Report Years Considered
Figure 11. Global Growth Hormone Deficiency Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Growth Hormone Deficiency Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Growth Hormone Deficiency Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global Growth Hormone Deficiency Therapy Market Share by Regions (2022-2027)
Figure 15. Global Growth Hormone Deficiency Therapy Market Share by Players in 2020
Figure 16. Global Top Growth Hormone Deficiency Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Growth Hormone Deficiency Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Growth Hormone Deficiency Therapy Revenue in 2020
Figure 18. Global Growth Hormone Deficiency Therapy Revenue Market Share by Type (2016-2021)
Figure 19. Global Growth Hormone Deficiency Therapy Revenue Market Share by Type (2022-2027)
Figure 20. North America Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Growth Hormone Deficiency Therapy Market Share by Type (2016-2027)
Figure 22. North America Growth Hormone Deficiency Therapy Market Share by Application (2016-2027)
Figure 23. North America Growth Hormone Deficiency Therapy Market Share by Country (2016-2027)
Figure 24. United States Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Growth Hormone Deficiency Therapy Market Share by Type (2016-2027)
Figure 28. Europe Growth Hormone Deficiency Therapy Market Share by Application (2016-2027)
Figure 29. Europe Growth Hormone Deficiency Therapy Market Share by Country (2016-2027)
Figure 30. Germany Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Growth Hormone Deficiency Therapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Growth Hormone Deficiency Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Growth Hormone Deficiency Therapy Market Share by Region (2016-2027)
Figure 40. China Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Growth Hormone Deficiency Therapy Market Share by Type (2016-2027)
Figure 48. Latin America Growth Hormone Deficiency Therapy Market Share by Application (2016-2027)
Figure 49. Latin America Growth Hormone Deficiency Therapy Market Share by Country (2016-2027)
Figure 50. Mexico Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Growth Hormone Deficiency Therapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Growth Hormone Deficiency Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Growth Hormone Deficiency Therapy Market Share by Country (2016-2027)
Figure 56. Turkey Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Growth Hormone Deficiency Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Eli Lilly Revenue Growth Rate in Growth Hormone Deficiency Therapy Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Growth Hormone Deficiency Therapy Business (2016-2021)
Figure 61. AbbVie Revenue Growth Rate in Growth Hormone Deficiency Therapy Business (2016-2021)
Figure 62. Novo Nordisk Revenue Growth Rate in Growth Hormone Deficiency Therapy Business (2016-2021)
Figure 63. Merck KGaA Revenue Growth Rate in Growth Hormone Deficiency Therapy Business (2016-2021)
Figure 64. Mylan Revenue Growth Rate in Growth Hormone Deficiency Therapy Business (2016-2021)
Figure 65. Bayer Revenue Growth Rate in Growth Hormone Deficiency Therapy Business (2016-2021)
Figure 66. Teva Revenue Growth Rate in Growth Hormone Deficiency Therapy Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Growth Hormone Deficiency Therapy Business (2016-2021)
Figure 68. Abbott Revenue Growth Rate in Growth Hormone Deficiency Therapy Business (2016-2021)
Figure 69. Roche Revenue Growth Rate in Growth Hormone Deficiency Therapy Business (2016-2021)
Figure 70. Endo International Revenue Growth Rate in Growth Hormone Deficiency Therapy Business (2016-2021)
Figure 71. Ipsen Revenue Growth Rate in Growth Hormone Deficiency Therapy Business (2016-2021)
Figure 72. ANI Pharmaceuticals Revenue Growth Rate in Growth Hormone Deficiency Therapy Business (2016-2021)
Figure 73. TherapeuticsMD Revenue Growth Rate in Growth Hormone Deficiency Therapy Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3783 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、α1アンチトリプシン欠乏症増強療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（グラシア、アララストNP、プロラスチンC、その他）、用途別市場規模（病院、専門診療所）、主要地域別市場規模（北米、アメ...

世界のがんホルモン療法剤市場規模・現状・予測（2021年-2027年）

Global Cancer Hormone Therapy Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3955 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、がんホルモン療法剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（タモキシフェン、アロマターゼ阻害剤、抗アンドロゲン剤、アンドロゲン合成阻害剤、その他）、用途別市場規模（乳がん、前立腺がん）、主要地域...

世界のCDKL5欠乏症（CDD）市場規模・現状・予測（2021年-2027年）

Global CDKL5 Deficiency Disorder (CDD) Market Size, Status and Forecast 2021-2027
QFJ1-3983 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、CDKL5欠乏症（CDD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（従来型医薬品、新型医薬品）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界のホルモン不応性乳がん市場規模・現状・予測（2021年-2027年）

Global Hormone Refractory Breast Cancer Market Size, Status and Forecast 2021-2027
QFJ1-4319 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ホルモン不応性乳がんの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍マーカー療法、遺伝子発現療法、遺伝子変異療法）、用途別市場規模（科学研究生産、生物科学技術、医療技術、医療機器）、主要地域別市場...

世界のアルギナーゼ欠損症治療薬市場規模・現状・予測（2021年-2027年）

Global Arginase Deficiency Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3850 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、アルギナーゼ欠損症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界のアルギナーゼ欠損症治療市場規模・現状・予測（2021年-2027年）

Global Arginase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3851 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、アルギナーゼ欠損症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界のACTH欠乏症治療市場規模・現状・予測（2021年-2027年）

Global ACTH Deficiency Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3753 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ACTH欠乏症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（先天性、後天性）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界のオルニチン-トランスカルバミラーゼ欠損症市場規模・現状・予測（2021年-2027年）

Global Ornithine-Transcarbamylase Deficiency Market Size, Status and Forecast 2021-2027
QFJ1-4629 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、オルニチン-トランスカルバミラーゼ欠損症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（DTX-301、SEL-313、SHP-641、PRX-OTC、その他）、用途別市場規模（病院、クリニック、その...

世界のビオチニダーゼ欠損症市場規模・現状・予測（2021年-2027年）

Global Biotinidase Deficiency Market Size, Status and Forecast 2021-2027
QFJ1-5622 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、ビオチニダーゼ欠損症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（重度ビオチニダーゼ欠損症、部分的ビオチニダーゼ欠損症）、用途別市場規模（病院、専門クリニック、ドラッグストア、小売薬局、オンライン薬...

世界の亜鉛欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Zinc Deficiency Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5049 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、亜鉛欠乏症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口剤、注射剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界のα1アンチトリプシン欠乏症増強療法市場規模・現状・予測（2021年-2027年） Alpha-1 antitrypsin deficiency (AATD) is an inherited condition characterized as a low or unpredictable level of alpha-1 protein, generated by liver. The disease most commonly affects lungs and liver and is often undiagnosed. Augmentation therapy is the most specific therapy for the treatment of AAT…
世界のがんホルモン療法剤市場規模・現状・予測（2021年-2027年） Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer. Market Analysis and Insights: Global Cancer H…
α1-アンチトリプシン(AAT)欠乏症増強療法のグローバル市場：規模・現状・予測2019-2025 Alpha-1 antitrypsin deficiency (AATD) is an inherited condition characterized as a low or unpredictable level of alpha-1 protein, generated by liver. The disease most commonly affects lungs and liver and is often undiagnosed. Augmentation therapy is the most specific therapy for the treatment of AAT…
α1-アンチトリプシン(AAT)欠乏症増強療法のグローバル市場：規模・現状・予測2019-2025 Alpha-1 antitrypsin deficiency (AATD) is an inherited condition characterized as a low or unpredictable level of alpha-1 protein, generated by liver. The disease most commonly affects lungs and liver and is often undiagnosed. Augmentation therapy is the most specific therapy for the treatment of AAT…
ホルモン補充療法のグローバル市場2021 Hormone replacement therapy refers to the treatment of the patients with hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low. Market competition is intense. Eli Lilly, Pfizer, AbbVie, Novo N…